natgillin/translations-raw huggingface dataset:
PegIntron is supplied as: - 1 vial of powder for solution for injection and 1 ampoule of solvent for parenteral use; - 1 vial of powder for solution for injection, 1 ampoule of solvent for parenteral use, 1 injection syringe, 2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for parenteral use; - 4 vials of powder for solution for injection, 4 ampoules of solvent for parenteral use, 4 injection syringes, 8 injection needles and 4 cleansing swabs; - 6 vials of powder for solution for injection and 6 ampoules of solvent for parenteral use. 
PegIntron je na voljo v naslednjih pakiranjih: - 1 viala s praškom za raztopino za injiciranje in 1 ampula z vehiklom za parenteralno uporabo, - 1 viala s praškom za raztopino za injiciranje, 1 ampula z vehiklom za parenteralno uporabo, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon, - 4 viale s praškom za raztopino za injiciranje in 4 ampule z vehiklom za parenteralno uporabo, - 4 viale s praškom za raztopino za injiciranje, 4 ampule z vehiklom za parenteralno uporabo, 4 injekcijske brizge, 8 injekcijskih igel in 4 čistilni tamponi, - 6 vial s praškom za raztopino za injiciranje in 6 ampul z vehiklom za parenteralno uporabo, - 12 vial s praškom za raztopino za injiciranje, 12 ampul z vehiklom za parenteralno uporabo, 12 injekcijskih brizg, 24 injekcijskih igel in 12 čistilnih tamponov.
- Interferon alfa-2b (3 MIU three times a week) + ribavirin (1,000/1,200 mg/day) (n = 505). 
+ ribavirin (1.000/1.200 mg/dan) (n = 514) - Interferon alfa-2b (3 mio i.e. 3-krat na teden) + ribavirin (1.000/1.200 mg/dan) (n = 505)
Therefore, each pre-filled pen contains an excess amount of solvent and PegIntron powder to ensure delivery of the labelled dose in 0.5 ml of PegIntron, solution for injection. 
Zato vsak napolnjen injekcijski peresnik vsebuje dodatno količino vehikla in praška PegIntron, da zagotovimo dajanje odmerka, ki je naveden na nalepki, v 0,5 ml zdravila PegIntron, raztopina za injiciranje.
SVR % (n/N) 99 % CI 
tednu % (n/N) 99 % IZ 99 % IZ
Careful co-administration of theophylline with the product (PegIntron) is recommended. 
Pri sočasni uporabi teofilina z zdravilom PegIntron je potrebna previdnost.
Volume of PegIntron to administer (ml) 
Volumen zdravila PegIntron za injiciranje (ml)
PegIntron is injected subcutaneously after reconstituting the powder as instructed, attaching a needle and setting the prescribed dose. 
Po rekonstituciji praška v skladu z navodili, postavitvi igle na peresnik in nastavitvi predpisanega odmerka se zdravilo PegIntron injicira subkutano.
Please refer to the ribavirin and boceprevir Summary of Product Characteristics (SmPCs) when PegIntron is to be used in combination with these medicines. 
V primeru uporabe zdravila PegIntron z ribavirinom in boceprevirjem, prosimo, glejte Povzetka glavnih značilnosti zdravila (SmPC) za ti dve zdravili.
Please refer to the ribavirin SmPC when PegIntron is to be used in combination with ribavirin. 
V primeru uporabe zdravila PegIntron v kombinaciji z ribavirinom, prosimo, glejte SmPC za ribavirin.
2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for injection; - 4 vials of powder for solution for injection, 4 ampoules of solvent for injection, 4 injection syringes, 8 injection needles and 4 cleansing swabs; - 6 vials of powder for solution for injection and 6 ampoules of solvent for injection; - 12 vials of powder for solution for injection, 12 ampoules of solvent for injection, 12 injection syringes, 24 injection needles and 12 cleansing swabs. 
Zdravilo PegIntron je na voljo v različnih velikostih pakiranj: - 1 viala praška za raztopino za injiciranje in 1 ampula vehikla za injiciranje; - 1 viala praška za raztopino za injiciranje, 1 ampula vehikla za injiciranje, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon; - 4 viale praška za raztopino za injiciranje in 4 ampule vehikla za injiciranje; - 4 viale praška za raztopino za injiciranje, 4 ampule vehikla za injiciranje, 4 injekcijske brizge, 8 injekcijskih igel in 4 čistilni tamponi; - 6 vial praška za raztopino za injiciranje in 6 ampul vehikla za injiciranje; - 12 vial praška za raztopino za injiciranje in 12 ampul vehikla za injiciranje, 12 injekcijskih brizg, 24 injekcijskih igel in 12 čistilnih tamponov.
The lowest PegIntron strength available is 50 g/0.5 ml; therefore for patients prescribed 0.5 g/kg/week, doses must be adjusted by volume as shown in Table 2. 
Bolnikom, ki jim predpišete odmerek 0,5 g/kg/teden, morate torej volumsko prilagoditi odmerek, kot je prikazano v preglednici 2.
Tell your doctor or healthcare professional or the doctor or healthcare professional of the child you are caring for as soon as possible. 
Če ste uporabili večji odmerek zdravila PegIntron, kot bi smeli Čimprej povejte zdravniku ali zdravstvenemu delavcu ali zdravniku ali zdravstvenemu delavcu otroka, za katerega skrbite.
PegIntron 80 micrograms powder and solvent for solution for injection EU/1/00/131/006 
PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/006
PegIntron 120 micrograms powder and solvent for solution for injection EU/1/00/131/016 
PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/016
PegIntron monotherapy - Adults 
Monoterapija z zdravilom PegIntron - odrasli bolniki Odmerek za injiciranje
PegIntron 150 micrograms - vial of powder 
PegIntron 150 mikrogramov - viala praška
nd dose reduction of PegIntron is to 20 g/m 2/week. 
Najmanjša jakost zdravila PegIntron je 50 g/0,5 ml.
PegIntron 150 micrograms powder and solvent for solution for injection EU/1/00/131/021 
PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/021
PegIntron 120 micrograms - vial of powder 
PegIntron 120 mikrogramov - viala praška
PegIntron 80 micrograms - vial of powder 
PegIntron 80 mikrogramov - viala praška
Very common side effects (may affect more than 1 in 10 people): - feeling depressed, irritability, trouble falling asleep or staying asleep, feeling anxious or nervous, difficulty concentrating, mood swings, - headache, dizziness, tired feeling, shaking chills, fever, flu-like symptoms, virus infection, 
Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov): - depresija, razdražljivost, težave z uspavanjem ali zbujanje, tesnoba ali živčnost, težave s koncentracijo, nihanje razpoloženja, - glavobol, omotica, občutek utrujenosti, mrzlica s tresenjem, zvišana telesna temperatura, gripi podobni simptomi, virusna okužba, šibkost, - oteženo dihanje, faringitis (vneto grlo), kašelj,
The following treatment-related adverse reactions were reported in adults in clinical trials or through post-marketing surveillance in patients treated with peginterferon alfa-2b, including PegIntron monotherapy or PegIntron/ribavirin. 
Med zdravljenjem so v času kliničnih preizkušanj ali v obdobju spremljanja zdravila na trgu pri odraslih bolnikih zdravljenih s peginterferonom alfa-2b, vključno z monoterapijo z zdravilom PegIntron ali s kombinirano terapijo z zdravilom PegIntron in ribavirinom poročali o naslednjih neželenih učinkih, povezanih z zdravljenjem.
Dental and periodontal disorders, which may lead to loss of teeth, have been reported in patients receiving PegIntron and ribavirin combination therapy. 
Pri bolnikih, ki so prejemali zdravilo PegIntron z ribavirinom v kombinirani terapiji, so poročali o boleznih zob in obzobnega tkiva, ki lahko vodijo do izgube zob.
- pain in joints and muscles, muscle and bone pain. 
bolečine v kosteh, mišična šibkost
if you are a girl or a woman of childbearing age who is taking ribavirin: you must have a negative pregnancy test before treatment, each month during treatment, and for the 4 months after treatment is stopped. 
Test nosečnosti mora biti pri vas negativen pred zdravljenjem, vsak mesec med zdravljenjem in še 4 mesece po zaključku zdravljenja.
How to store PegIntron 
Shranjevanje zdravila PegIntron
PegIntron 50 micrograms powder and solvent for solution for injection EU/1/00/131/001 
PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/001
PegIntron 100 micrograms powder and solvent for solution for injection EU/1/00/131/011 
PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/131/011
PegIntron 50 micrograms - vial of powder 
PegIntron 50 mikrogramov - viala praška
PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b 
PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku peginterferon alfa-2b
Careful co-administration of thioridazine with the product (PegIntron) is recommended. 
Pri sočasni uporabi tioridazina z zdravilom PegIntron je potrebna previdnost.
PegIntron contains sucrose 
Zdravilo PegIntron vsebuje saharozo
PegIntron 100 micrograms - vial of powder 
PegIntron 100 mikrogramov - viala praška
PegIntron 50 micrograms powder and solvent for solution for injection PegIntron 80 micrograms powder and solvent for solution for injection PegIntron 100 micrograms powder and solvent for solution for injection PegIntron 120 micrograms powder and solvent for solution for injection PegIntron 150 micrograms powder and solvent for solution for injection peginterferon alfa-2b 
PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje peginterferon alfa-2b
PegIntron 50 micrograms powder and solvent for solution for injection PegIntron 80 micrograms powder and solvent for solution for injection PegIntron 100 micrograms powder and solvent for solution for injection PegIntron 120 micrograms powder and solvent for solution for injection PegIntron 150 micrograms powder and solvent for solution for injection 
PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje
Both the Metavir score and Ishak grade decreased among subjects treated with PegIntron in combination with ribavirin. 
Pri preiskovancih, zdravljenih z zdravilom PegIntron v kombinaciji z ribavirinom, sta se zmanjšali tako ocena po Metavirju kot ocena po Ishaku.
EU/1/00/131/008 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/009 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs) 
EU/1/00/131/008 (4 viale praška, 4 ampule vehikla) EU/1/00/131/009 (4 viale praška, 4 ampule vehikla, 4 injekcijske brizge, 8 injekcijskih igel, 4 čistilni tamponi)
The pharmacokinetics of PegIntron have not been evaluated in patients with severe hepatic dysfunction. 
Okvara jeter Pri bolnikih s hudo jetrno okvaro farmakokinetike zdravila PegIntron niso ocenjevali.
The following treatment-related adverse reactions were reported in the study in children and adolescent patients treated with PegIntron in combination with ribavirin. 
V študiji pri otrocih in mladostnikih, zdravljenih z zdravilom PegIntron v kombinaciji z ribavirinom, so poročali o naslednjih z zdravljenjem povezanih neželenih učinkih.
EU/1/00/131/003 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/004 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs) 
EU/1/00/131/003 (4 viale praška, 4 ampule vehikla) EU/1/00/131/004 (4 viale praška, 4 ampule vehikla, 4 injekcijske brizge, 8 injekcijskih igel, 4 čistilni tamponi)
Package inserts of theophylline should be referred to when co-administering with the product (PegIntron) 
Pri sočasni uporabi z zdravilom PegIntron je treba upoštevati navodilo za uporabo teofilina.
PegIntron 80 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution. 
PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje Eno vialo se rekonstituira z 0,7 ml vode za injekcije za dajanje do 0,5 ml raztopine.
Pen label - PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen 
Nalepka na peresniku - PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
Pen label - PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen 
Nalepka na peresniku - PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
Metabolism of thioridazine is suppressed by inhibitory action of the product (PegIntron) on CYP2D6. 
Zaviralni učinek zdravila PegIntron na CYP2D6 upočasni presnovo tioridazina.
Also see SmPCs for ribavirin and boceprevir if PegIntron is to be administered in combination therapy in patients with chronic hepatitis C. 
Pri uporabi zdravila PegIntron v kombinirani terapiji pri bolnikih s kroničnim hepatitisom C glejte tudi SmPC za ribavirin in boceprevir.
EU/1/00/131/011 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/012 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab) 
EU/1/00/131/011 (1 viala praška, 1 ampula vehikla) EU/1/00/131/012 (1 viala praška, 1 ampula vehikla, 1 injekcijska brizga, 2 injekcijski igli, 1 čistilni tampon)
Pen label - PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen 
Nalepka na peresniku - PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
st dose reduction of PegIntron is to 40 g/m 2/week, 2 
Začetni odmerek 60 g/m2/teden zmanjšate na 40 g/m2/teden in nato na
Carton 150 micrograms powder and solvent for solution for injection in pre-filled pen 
PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
Discard the PegIntron pre-filled pen (CLEARCLICK) with any solution that is left in it after you give yourself the injection. 
Morebitno raztopino, ki po injiciranju zdravila še ostane v PegIntron napolnjenem injekcijskem peresniku (CLEARCLICK), zavrzite.
PegIntron 80 micrograms powder for injection peginterferon alfa-2b 
PegIntron 80 mikrogramov prašek za injekcijo peginterferon alfa-2b s.c.
EU/1/00/131/006 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/007 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab) 
EU/1/00/131/006 (1 viala praška, 1 ampula vehikla) EU/1/00/131/007 (1 viala praška, 1 ampula vehikla, 1 injekcijska brizga, 2 injekcijski igli, 1 čistilni tampon)
EU/1/00/131/047 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/048 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/050 (12 pens, 12 injection needles and 24 cleansing swabs) 
EU/1/00/131/047 (1 peresnik, 1 injekcijska igla in 2 čistilna tampona) EU/1/00/131/048 (4 peresniki, 4 injekcijske igle in 8 čistilnih tamponov) EU/1/00/131/050 (12 peresnikov, 12 injekcijskih igel in 24 čistilnih tamponov)
The plasma half-life of PegIntron is prolonged compared with nonpegylated interferon alfa-2b. 
V primerjavi z nepegiliranim interferonom alfa-2b je njegova razpolovna doba v plazmi daljša.
PegIntron 150 micrograms powder and solvent for solution for injection Each vial contains 150 micrograms of peginterferon alfa-2b measured on a protein basis. 
PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 150 mikrogramov peginterferona alfa-2b, merjeno na proteinski osnovi.
EU/1/00/131/016 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/017 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab) 
EU/1/00/131/016 (1 viala praška, 1 ampula vehikla) EU/1/00/131/017 (1 viala praška, 1 ampula vehikla, 1 injekcijska brizga, 2 injekcijski igli, 1 čistilni tampon)
PegIntron 150 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution. 
PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje Eno vialo se rekonstituira z 0,7 ml vode za injekcije za dajanje do 0,5 ml raztopine.
PegIntron 120 micrograms powder and solvent for solution for injection Each vial contains 120 micrograms of peginterferon alfa-2b measured on a protein basis. 
PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 120 mikrogramov peginterferona alfa-2b, merjeno na proteinski osnovi.
PegIntron 80 micrograms powder and solvent for solution for injection Each vial contains 80 micrograms of peginterferon alfa-2b measured on a protein basis. 
PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 80 mikrogramov peginterferona alfa-2b, merjeno glede na beljakovine.
HCV/HIV Co-infected patients 
Bolniki, sočasno okuženi s HCV / HIV
HCV/HIV co-infected patients 
Bolniki, sočasno okuženi s HCV/HIV
PegIntron 120 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution. 
PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje Eno vialo se rekonstituira z 0,7 ml vode za injekcije za dajanje do 0,5 ml raztopine.
EU/1/00/131/035 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/036 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/038 (12 pens, 12 injection needles and 24 cleansing swabs) 
EU/1/00/131/035 (1 peresnik, 1 injekcijska igla in 2 čistilna tampona) EU/1/00/131/036 (4 peresniki, 4 injekcijske igle in 8 čistilnih tamponov) EU/1/00/131/038 (12 peresnikov, 12 injekcijskih igel in 24 čistilnih tamponov)
PegIntron 120 micrograms powder for injection peginterferon alfa-2b 
PegIntron 120 mikrogramov prašek za injekcijo peginterferon alfa-2b s.c.
Pen label - PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen 
Nalepka na peresniku - PegIntron 80 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
EU/1/00/131/043 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/044 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/046 (12 pens, 12 injection needles and 24 cleansing swabs) 
EU/1/00/131/043 (1 peresnik, 1 injekcijska igla in 2 čistilna tampona) EU/1/00/131/044 (4 peresniki, 4 injekcijske igle in 8 čistilnih tamponov) EU/1/00/131/046 (12 peresnikov, 12 injekcijskih igel in 24 čistilnih tamponov)
EU/1/00/131/021 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/022 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab) 
EU/1/00/131/021 (1 viala praška, 1 ampula vehikla) EU/1/00/131/022 (1 viala praška, 1 ampula vehikla, 1 injekcijska brizga, 2 injekcijski igli, 1 čistilni tampon)
nd dose reduction of PegIntron is to 0.5 µg/kg/week. 
Če je potrebno, lahko še drugič zmanjšate odmerek zdravila PegIntron, in sicer na 0,5 µg/kg/teden.
EU/1/00/131/039 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/040 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/042 (12 pens, 12 injection needles and 24 cleansing swabs) 
EU/1/00/131/039 (1 peresnik, 1 injekcijska igla in 2 čistilna tampona) EU/1/00/131/040 (4 peresniki, 4 injekcijske igle in 8 čistilnih tamponov) EU/1/00/131/042 (12 peresnikov, 12 injekcijskih igel in 24 čistilnih tamponov)
PegIntron 50 micrograms powder for injection peginterferon alfa-2b 
PegIntron 50 mikrogramov prašek za injekcijo peginterferon alfa-2b s.c.
PegIntron 100 micrograms powder and solvent for solution for injection Each vial contains 100 micrograms of peginterferon alfa-2b measured on a protein basis. 
PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 100 mikrogramov peginterferona alfa-2b, merjeno na proteinski osnovi.
Pen label - PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen 
Nalepka na peresniku - PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
EU/1/00/131/001 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/002 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab) 
EU/1/00/131/001 (1 viala praška, 1 ampula vehikla) EU/1/00/131/002 (1 viala praška, 1 ampula vehikla, 1 injekcijska brizga, 2 injekcijski igli, 1 čistilni tampon)
PegIntron 150 micrograms powder for injection peginterferon alfa-2b 
PegIntron 150 mikrogramov prašek za injekcijo peginterferon alfa-2b s.c.
PegIntron 100 micrograms powder for injection peginterferon alfa-2b 
PegIntron 100 mikrogramov prašek za injekcijo peginterferon alfa-2b s.c.
PegIntron 150 micrograms powder and solvent for solution for injection Each vial contains 150 micrograms of peginterferon alfa-2b as measured on a protein basis. 
PegIntron 150 mikrogramov prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 150 mikrogramov peginterferona alfa-2b, merjeno glede na beljakovine.
PegIntron 50 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution. 
PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje Eno vialo se rekonstituira z 0,7 ml vode za injekcije za dajanje do 0,5 ml raztopine.
PegIntron 50 micrograms powder and solvent for solution for injection Each vial contains 50 micrograms of peginterferon alfa-2b measured on a protein basis. 
PegIntron 50 mikrogramov prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 50 mikrogramov peginterferona alfa-2b, merjeno glede na beljakovine.
PegIntron 100 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution. 
PegIntron 100 mikrogramov prašek in vehikel za raztopino za injiciranje Eno vialo se rekonstituira z 0,7 ml vode za injekcije za dajanje do 0,5 ml raztopine.
st dose reduction of PegIntron is to 1 µg/kg/week. 
Opomba 2: Pri odraslih bolnikih je prvo zmanjšanje odmerka zdravila PegIntron na 1 µg/kg/teden.
- Break off the top of the ampoule of solvent. 
- Odlomite vrh ampule z vehiklom.
EU/1/00/131/031 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/032 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/034 (12 pens, 12 injection needles and 24 cleansing swabs) 
EU/1/00/131/031 (1 peresnik, 1 injekcijska igla in 2 čistilna tampona) EU/1/00/131/032 (4 peresniki, 4 injekcijske igle in 8 čistilnih tamponov) EU/1/00/131/034 (12 peresnikov, 12 injekcijskih igel in 24 čistilnih tamponov)
PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b 
PegIntron 120 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku peginterferon alfa-2b